Right Ventricular Function in Patients With Left Ventricular Assist Device Support by Pulsatile Polvad MEV and Continuous-Flow Pumps Heartware and Heartmate II

被引:0
|
作者
Nadziakiewicz, P. [1 ]
Borkowski, J. [1 ]
Szygula-Jurkiewicz, B. [2 ]
Niklewski, T. [3 ]
Pacholewicz, J. [3 ]
Zakliczynski, M. [3 ]
Hrapkowic, T. [3 ]
Zennbala, M. [3 ]
机构
[1] Silesian Ctr Heart Dis, Dept Cardiac Anesthesia & Intens Care SUM, Ul Sklodowskiej Curie 9, PL-41800 Zabrze, Poland
[2] Med Univ Silesia, SMDZ Zabrze, Clin Dept Cardiac Anesthesia & Intens Care, Katowice, Poland
[3] Silesian Ctr Heart Dis, Dept Cardiac Surg & Transplantat SUM, Zabrze, Poland
关键词
CLINICAL-EXPERIENCE; IMPLANTATION; FAILURE; DYSFUNCTION;
D O I
10.1016/j.transproceed.2016.01.065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Left ventricular assist device (LVAD) support is increasingly used in patients with heart failure. The right ventricle (RV) plays a main role in LVAD support. Little is known about the effects of pulsatile Polvad MEV devices or continuouseconds flow pumps on RV function. We compared hemodynamic parameters of RV in patients after implantation of Polvad MEV (PM) and Heartware (HW) or Heartmate II (HMII) LVADs. Methods. Forty-four patients were retrospectively reviewed after implantation of PM (group P; n = 24 [21 M, 3 F]) or HW or HMII (group C; n = 20 [20 M, 0 F]) LVADs from April 2007 to February 2014. Hemodynamic data mean pulmonary pressure (mPAP), central venous pressure (CVP), cardiac output (CO), and cardiac index (CI) were collected before surgery, after surgery, and every 2 hours in the intensive care unit, with the time points numbered from 1 to 120. Right ventricular work (RVW) was calculated according to the equation: RCW = CO x (mPAP - CVP) x 0.0144 (g.m). Results. Baseline characteristic of the patients were similar. mPAP values were similar between groups. CVP values were higher in group P, significantly at time points 5 and 7-33. CO values were higher in group C, significantly from point 3 and almost all the time to point 43. CI reached significance at point 9, 12-14, 16-19, and 30-41. RCW was higher in group P before implantation. Post-implantation RCW values were higher in group C, significantly at time points 19, 20, 32-34, 51-53, and 55-57. Conclusions. Continuous-flow pumps more effectively optimize RV function than pulsatile LVADs, which can result in more effective prevention of RV failure or insuffiency in that group.
引用
收藏
页码:1786 / 1790
页数:5
相关论文
共 50 条
  • [1] Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function
    Lee, Sangjin
    Kamdar, Forum
    Madlon-Kay, Richard
    Boyle, Andrew
    Colvin-Adams, Monica
    Pritzker, Marc
    John, Ranjit
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : 209 - 215
  • [2] Impact of continuous-flow left ventricular assist device support on right ventricular function
    Morgan, Jeffrey A.
    Paone, Gaetano
    Nemeh, Hassan W.
    Murthy, Raghav
    Williams, Celeste T.
    Lanfear, David E.
    Tita, Cristina
    Brewer, Robert J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : 398 - 403
  • [3] Effects of the HeartMate II Continuous-Flow Left Ventricular Assist Device on RV Function
    Lee, Sangjin
    Kamdar, Forum
    Madlon-Kay, Richard
    John, Ranjit
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A180 - A180
  • [4] Effects of the HeartMate II Continuous-Flow Left Ventricular Assist Device on RV Function
    Lee, S.
    Kamdar, F.
    Madlon-Kay, R.
    John, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S277 - S277
  • [5] Outcomes and Readmissions After Continuous Flow Left Ventricular Assist Device: Heartmate II Versus Heartware Ventricular Assist Device
    Tuncer, O. N.
    Kemaloglu, C.
    Erbasan, O.
    Golbasi, I.
    Turkay, C.
    Bayezid, O.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (06) : 2157 - 2161
  • [6] HeartMate® II continuous-flow left ventricular assist system
    Sheikh, Farooq H.
    Russell, Stuart D.
    EXPERT REVIEW OF MEDICAL DEVICES, 2011, 8 (01) : 11 - 21
  • [7] Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device
    Shin, Kinam
    Cho, Won Chul
    Shin, Nara
    Kim, Hong Rae
    Kim, Min-Seok
    Chung, Cheol Hyun
    Jung, Sung-Ho
    JOURNAL OF CHEST SURGERY, 2024, 57 (02): : 184 - 194
  • [8] Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes
    Kormos, Robert L.
    Teuteberg, Jeffrey J.
    Pagani, Francis D.
    Russell, Stuart D.
    John, Ranjit
    Miller, Leslie W.
    Massey, Todd
    Milano, Carmelo A.
    Moazami, Nader
    Sundareswaran, Kartik S.
    Farrar, David J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 139 (05): : 1316 - 1324
  • [9] Application of the heartmate II risk score in patients with heartware left ventricular assist device
    Rao, S. D.
    Hayward, C. S.
    Macdonald, P. S.
    Keogh, A. M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 299 - 299
  • [10] Renal and Hepatic Function Improve in Advanced Heart Failure Patients During Continuous-Flow Support With the HeartMate II Left Ventricular Assist Device
    Russell, Stuart D.
    Rogers, Joseph G.
    Milano, Carmelo A.
    Dyke, David B.
    Pagani, Francis D.
    Aranda, Juan M.
    Klodell, Charles T., Jr.
    Boyle, Andrew J.
    John, Ranjit
    Chen, Leway
    Massey, H. Todd
    Farrar, David J.
    Conte, John V.
    CIRCULATION, 2009, 120 (23) : 2352 - 2357